(CIDRAP News) The National Institute of Allergy and Infectious Diseases (NIAID) has released a 68-page report on its plan for expanding research on "Category A" bioterrorism agents: anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers, and botulism.
Editor's note: This story was updated Jan 30, 2003, with additional information from the Department of Health and Human Services.
(CIDRAP News) – President Bush yesterday proposed an initiative, called Project Bioshield, to speed the development and production of vaccines and treatments for smallpox, anthrax, botulism, and other diseases that could be spread by terrorists.
(CIDRAP News) The World Health Organization (WHO) reports that 50 people in the Congo have died of a suspected acute hemorrhagic fever syndrome. A Reuters report said the disease is suspected to be Ebola virus infection.
(CIDRAP News) The head of the World Health Organization's (WHO's) communicable disease programs says severe acute respiratory syndrome (SARS) may pose a more serious global health threat than any other new disease in the past 20-plus years, with the sole exception of AIDS.
(CIDRAP News) – Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have determined that a single injection of a fast-acting experimental Ebola vaccine confers protection against the disease in monkeys after just 1 month.
(CIDRAP News) Federal health officials yesterday released a 37-page report that they say demonstrates "tremendous progress" in developing countermeasures for bioterrorism through federally funded research since early 2002.
(CIDRAP News) The National Institutes of Health (NIH) today announced the start of the first human trial of a vaccine for Ebola virus infection, a currently untreatable disease that kills most of its victims.